Cell proliferation and inhibition of apoptosis are related to c-Kit activation in leukaemic lymphoblasts

References

• Ching-Hon P, Leslie R, Thomas LA. Acute lymphoblastic leukaemia. Lancet. 2008;371(9617):1030–1043. doi: 10.1016/S0140-6736(08)60457-2
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013
   PubMed Web of Science ®Google Scholar
• Liang J, Wu YL, Chen BJ, et al. The C-Kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci. 2013;9(5):435–443. doi: 10.7150/ijbs.6087
   PubMed Web of Science ®Google Scholar
• Kang ZJ, Liu YF, Xu LZ, et al. The Philadelphia chromosome in leukemogenesis. Chin J Cancer. 2016;35:48. doi: 10.1186/s40880-016-0108-0
   PubMed Web of Science ®Google Scholar
• Vázquez-Franco JE, Reyes-Maldonado E, Vela-Ojeda J, et al. Src, Akt, NF-κB, BCL-2 and c-IAP1 may be involved in an anti-apoptotic effect in patients with BCR-ABL positive and BCR-ABL negative acute lymphoblastic leukemia. Leuk Res. 2012;36(7):862–867. doi: 10.1016/j.leukres.2012.03.020
   PubMed Web of Science ®Google Scholar
• Tohda S, Yang GS, Ashman LK, et al. Relationship between c-Kit expression and proliferation in acute myeloblastic leukemia cell lines. J Cell Physiol. 1993;154(2):410–418. doi: 10.1002/jcp.1041540225
   PubMed Web of Science ®Google Scholar
• Blume-Jensen P, Rönnstrand L, Gout I, et al. Modulation of Kit/stem cell factor receptor-induced signaling by protein kinase C. J Biol Chem. 1994;269(34):21793–21802.
   PubMed Web of Science ®Google Scholar
• Phung B, Sun J, Schepsky A, et al. C-KIT signaling depends on microphthalmia-associated transcription factor for effects on cell proliferation. PLoS One. 2011;6(8):e24064–00. doi: 10.1371/journal.pone.0024064
   PubMed Web of Science ®Google Scholar
• Hallek M, Danhauser-Riedl S, Herbst R, et al. Interaction of the receptor tyrosine kinase p145c-kit with the p210bcr/abl kinase in myeloid cells. Br J Haematol. 1996;94:5–16. doi: 10.1046/j.1365-2141.1996.6102053.x
   PubMed Web of Science ®Google Scholar
• Lezama R, Ortega A, Ordaz B, et al. Hyposmolarity-induced ErbB4 phosphorylation and its influence on the non-receptor tyrosine kinase network response in cultured cerebellar granule neurons. J Neurochem. 2005;93(5):1189–1198. doi: 10.1111/j.1471-4159.2005.03110.x
   PubMed Web of Science ®Google Scholar
• Roskoski R. Signaling by Kit protein-tyrosine kinase—The stem cell factor receptor. Biochem Biophys Res Commun. 2005;337(1):1–13. doi: 10.1016/j.bbrc.2005.08.055
   PubMed Web of Science ®Google Scholar
• Serve H, Yee NS, Stella G, et al. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 1995;14(3):473–483. doi: 10.1002/j.1460-2075.1995.tb07023.x
   PubMed Web of Science ®Google Scholar
• Hira VVV, Van Noorden CJF, Carraway HE, et al. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches. Biochim Biophys Acta - Rev Cancer. 2017;1868(1):183–198. doi: 10.1016/j.bbcan.2017.03.010
   PubMed Web of Science ®Google Scholar
• Bowles KR, Jones L. Kinase signalling in Huntington’s disease. J Huntingtons Dis. 2014;3(2):89–123.
   PubMedGoogle Scholar
• Kim HJ, Hawke N, Baldwin AS. NF-κB and IKK as therapeutic targets in cancer. Cell Death Differ. 2006;13(5):738–747. doi: 10.1038/sj.cdd.4401877
   PubMed Web of Science ®Google Scholar
• Hinz M, Krappmann D, Eichten A, et al. NF-κB Function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition. Mol Cell Biol. 1999;19(4):2690–2698. doi: 10.1128/MCB.19.4.2690
   PubMed Web of Science ®Google Scholar
• Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med. 1997;3(8):917–921. doi: 10.1038/nm0897-917
   PubMed Web of Science ®Google Scholar
• Vázquez-Franco JE, Reyes-Maldonado E, Montiel-Cervantes LA, et al. Undifferentiated immunophenotypes and not expression of BCR-ABL can be associated in adult Mestizo Mexican patients with ALL. Rev Investig Clin. 2012;64(1):32–39.
   PubMedGoogle Scholar
• Edling CE, Hallberg B. c-Kit-A hematopoietic cell essential receptor tyrosine kinase. Int J Biochem Cell Biol. 2007;39(11):1995–1998. doi: 10.1016/j.biocel.2006.12.005
   PubMed Web of Science ®Google Scholar
• Shen HQ, Tang YM, Yang SL, et al. [Analysis of CD117 expression on leukemia cells]. Zhonghua Xue Ye Xue Za Zhi [Internet]. 2003;24(5):228–230. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12859870
   PubMedGoogle Scholar
• Colmone A, Amorim M, Pontier AL, et al. Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science. 2008;322:1861–1865. doi: 10.1126/science.1164390
   PubMed Web of Science ®Google Scholar
• Fukao T, Yamada T, Tanabe M, et al. Selective loss of gastrointestinal mast cells and impaired immunity in PI3K-deficient mice. Nat Immunol. 2002;3(3):295–304. doi: 10.1038/ni768
   PubMed Web of Science ®Google Scholar
• Young SM, Cambareri AC, Ashman LK. Role of c-KIT expression level and phosphatidylinositol 3-kinase activation in survival and proliferative responses of early myeloid cells. Cell Signal. 2006;18(5):608–620. doi: 10.1016/j.cellsig.2005.06.005
   PubMed Web of Science ®Google Scholar
• Grandage VL, Gale RE, Linch DC, et al. PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways. Leukemia. 2005;19(4):586–594. doi: 10.1038/sj.leu.2403653
   PubMed Web of Science ®Google Scholar
• Bai D, Ueno L, Vogt PK. Akt-mediated regulation of NFκB and the essentialness of NFκB for the oncogenicity of PI3K and Akt. Int J Cancer. 2009;125(12):2863–2870. doi: 10.1002/ijc.24748
   PubMed Web of Science ®Google Scholar
• Demchenko YN, Kuehl WM. A critical role for the NFkB pathway in multiple myeloma. Oncotarget [Internet]. 2010;1(1):59–68. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2947827&tool=pmcentrez&rendertype=abs tract
   PubMed Web of Science ®Google Scholar
• Tovar CF, Zeron HM, Romero MD, et al. Glycogen synthase kinase-3β (GSK-3β) and nuclear factor kappa-B (NFKB) in childhood acute lymphoblastic leukemia. Adv Clin Exp Med. 2016;25(6):1139–1147. doi: 10.17219/acem/63752
   PubMed Web of Science ®Google Scholar
• Fu M, Wang C, Li Z, et al. Minireview: cyclin D1: normal and abnormal functions. Endocrinology. 2004;145(12):5439–5447. doi: 10.1210/en.2004-0959
   PubMed Web of Science ®Google Scholar
• Brennan P, Mehl AM, Jones M, et al. Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells. Oncogene. 2002;21:1263–1271. doi: 10.1038/sj.onc.1205182
   PubMed Web of Science ®Google Scholar
• Chen C, Chang YC, Lan MS, et al. Leptin stimulates ovarian cancer cell growth and inhibits apoptosis by increasing cyclin D1 and Mcl-1 expression via the activation of the MEK/ERK1/2 and PI3K/Akt signaling pathways. Int J Oncol. 2013;42(3):1113–1119. doi: 10.3892/ijo.2013.1789
   PubMed Web of Science ®Google Scholar
• Hu Y, Dong X, Chu G, et al. miR-137 downregulates c-kit expression in acute myeloid leukemia. Leuk Res [Internet]. 2017;57:72–77. doi: 10.1016/j.leukres.2017.01.028
   PubMed Web of Science ®Google Scholar
• Perkins ND, Gilmore TD. Good cop, bad cop: the different faces of NF-κB. Cell Death Differ. 2006;13(5):759–772. doi: 10.1038/sj.cdd.4401838
   PubMed Web of Science ®Google Scholar
• Rönnstrand L. Signal transduction via the stem cell factor receptor/c-Kit. Cell Mol Life Sci. 2004;61(19–20):2535–2548. doi: 10.1007/s00018-004-4189-6
   PubMed Web of Science ®Google Scholar
• Elkholi R, Floros K V, Chipuk JE. The role of BH3-only proteins in tumor cell development, signaling, and treatment. Genes Cancer. 2011;2(5):523–537. doi: 10.1177/1947601911417177
   PubMedGoogle Scholar
• Graupner V, Alexander E, Overkamp T, et al. Differential regulation of the proapoptotic multidomain protein Bak by p53 and p73 at the promoter level. Cell Death Differ. 2011;18(7):1130–1139. doi: 10.1038/cdd.2010.179
   PubMed Web of Science ®Google Scholar
• Ashcroft M, Ludwig RL, Woods DB, et al. Phosphorylation of HDM2 by Akt. Oncogene. 2002;21:1955–1962. doi: 10.1038/sj.onc.1205276
   PubMed Web of Science ®Google Scholar
• Trino S, De Luca L, Laurenzana I, et al. P53-MDM2 pathway: evidences for a new targeted therapeutic approach in B-acute lymphoblastic leukemia. Front Pharmacol. 2016;7:1–7. doi: 10.3389/fphar.2016.00491
   PubMed Web of Science ®Google Scholar
• Ye Q, Cai W, Zheng Y, et al. ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer. Oncogene [Internet]. 2014;33(14):1828–1839. Available from: http://www.nature.com/doifinder/10.1038/onc.2013.122
   PubMed Web of Science ®Google Scholar
• Glienke W, Maute L, Wicht J, et al. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines. Tumour Biol. 2012;33(3):757–765. doi: 10.1007/s13277-011-0290-2
   PubMed Web of Science ®Google Scholar
• Asanuma H, Torigoe T, Kamiguchi K, et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells. Cancer Res. 2005;65(23):11018–11025. doi: 10.1158/0008-5472.CAN-05-0491
   PubMed Web of Science ®Google Scholar
• Vaira V, Lee CW, Goel HL, et al. Regulation of survivin expression by IGF-1/mTOR signaling. Oncogene. 2007;26(19):2678–2684. doi: 10.1038/sj.onc.1210094
   PubMed Web of Science ®Google Scholar
• Li W, Wang H, Kuang CY, et al. An essential role for the Id1/PI3K/Akt/NFkB/survivin signalling pathway in promoting the proliferation of endothelial progenitor cells in vitro. Mol Cell Biochem. 2012;363(1–2):135–145. doi: 10.1007/s11010-011-1166-x
   PubMed Web of Science ®Google Scholar
• Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-κB transcription factors. Oncogene. 1999;18:6910–6924. doi: 10.1038/sj.onc.1203238
   PubMed Web of Science ®Google Scholar
• Tang C, Lu Y-H, Xie J-H, et al. Downregulation of survivin and activation of caspase-3 through the PI3K/Akt pathway in ursolic acid-induced HepG2 cell apoptosis. Anticancer Drugs. 2009;20(4):249–258. doi: 10.1097/CAD.0b013e328327d476
   PubMed Web of Science ®Google Scholar